BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30126408)

  • 1. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.
    Huang L; Jansen L; Balavarca Y; Babaei M; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Primic-Žakelj M; Zadnik V; Besselink MG; Schrotz-King P; Brenner H
    BMC Med; 2018 Aug; 16(1):125. PubMed ID: 30126408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.
    Huang L; Jansen L; Balavarca Y; Molina-Montes E; Babaei M; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Fristrup CW; Mortensen MB; Primic-Žakelj M; Zadnik V; Becker N; Hackert T; Mägi M; Cassetti T; Sassatelli R; Grützmann R; Merkel S; Gonçalves AF; Bento MJ; Hegyi P; Lakatos G; Szentesi A; Moreau M; van de Velde T; Broeks A; Sant M; Minicozzi P; Mazzaferro V; Real FX; Carrato A; Molero X; Besselink MG; Malats N; Büchler MW; Schrotz-King P; Brenner H
    Gut; 2019 Jan; 68(1):130-139. PubMed ID: 29158237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003-2014: a large international population-based study.
    Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Primic-Žakelj M; Zadnik V; Mägi M; Pulte D; Schrotz-King P; Brenner H
    Int J Cancer; 2018 Dec; 143(12):3227-3239. PubMed ID: 29923613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
    Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
    BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
    Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States.
    Sirri E; Castro FA; Kieschke J; Jansen L; Emrich K; Gondos A; Holleczek B; Katalinic A; Urbschat I; Vohmann C; Brenner H
    Pancreas; 2016 Jul; 45(6):908-14. PubMed ID: 26745860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Shaib Y; Davila J; Naumann C; El-Serag H
    Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.
    Duffy A; Capanu M; Allen P; Kurtz R; Olson SH; Ludwig E; Klimstra DS; O'Reilly EM
    J Surg Oncol; 2009 Jul; 100(1):8-12. PubMed ID: 19384918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of pancreatic cancer and its prognosis-long-term therapeutic results after resection].
    Ohashi O; Yamamoto M; Ishida H; Saitoh Y
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1629-34. PubMed ID: 8886032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National failure to operate on early stage pancreatic cancer.
    Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS
    Ann Surg; 2007 Aug; 246(2):173-80. PubMed ID: 17667493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis.
    Li J; Liu L
    BMC Cancer; 2019 Jul; 19(1):726. PubMed ID: 31337369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study.
    Han D; Gao F; Liu JL; Wang H; Fu Q; Yang GW
    BMC Cancer; 2021 May; 21(1):560. PubMed ID: 34001035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors.
    Qadan M; Ma Y; Visser BC; Kunz PL; Fisher GA; Norton JA; Poultsides GA
    J Am Coll Surg; 2014 Feb; 218(2):188-95. PubMed ID: 24321190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer.
    Katz MH; Hu CY; Fleming JB; Pisters PW; Lee JE; Chang GJ
    Arch Surg; 2012 Jun; 147(6):513-9. PubMed ID: 22351874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.